Inactive Instrument

Press Releases Sanofi SA Nyse

Equities

US80105N1054

Real-time Estimate Cboe BZX Other stock markets 01:30:18 16/05/2024 am IST			5-day change	1st Jan Change
48.96 ^USD	+14.75%		-1.47%	-1.47%

05:00pm	Transcript : Sanofi Presents at Bank of America Health Care Conference 2024, May-15-2024 08:00 AM
14/05	Global markets live: Apple, Sony, Vodafone, Booking, Walmart...

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Enabling The "Full Scope" Of Claims In View Of The Supreme Court's Decision In Amgen	13/05	AQ
Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines	13/05	AQ
Novavax Reports First Quarter 2024 Financial Results and Operational Highlights	13/05	AQ
Press Release: Sanofi adds over €1 billion for biomanufacturing to €2.5 billion already committed in major projects in France to support health sovereignty	13/05	GL
Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines	10/05	GL
Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant RSV hospitalizations	02/05	GL
Press Release: Annual General Meeting of April 30, 2024	30/04	GL
The 16th Annual Global CSR & ESG Summit and Awards 2024: Celebrating Sustainable Leadership and Innovation, 25 April 2024	30/04	AQ
Media Update: New data presented at ATS demonstrate Sanofi’s leadership in advancing potential new therapies for patients with immune-mediated respiratory diseases	26/04	PU
Sanofi Q1 robust 7% sales growth driven by launches, underpins full-year guidance	26/04	AQ
Sanofi: Q1 Earnings Snapshot	25/04	AQ
Press Release: Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance	25/04	GL
AusBiotech announces incoming CEO	24/04	AQ
Sanofi - Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia	24/04	AQ
Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia	23/04	GL
Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia	23/04	AQ
The 2023 Pharmaceutical Patent Review	17/04	AQ
Press Release: New 48-week frexalimab phase 2 data support potential for high sustained efficacy in multiple sclerosis	17/04	GL
INNATE PHARMA ANNOUNCES ADVANCEMENT OF SANOFI-DEVELOPED NK CELL ENGAGER SAR443579/IPH6101 PROGRESSING TO PHASE 2 FOR BLOOD CANCER PATIENTS	16/04	AQ
Sanofi - AGM 30.04.2024 - Availability of Preparatory documents	08/04	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

SANOFI : Sanofi’s healthy Q1 performance hailed by markets

April 25, 2024 at 05:28 pm IST

Sanofi Sees Trend for Years of Steady Growth: CFO

February 04, 2023 at 02:26 am IST